Skip to content
Clinical Trials – home

Zazabie s.r.o.

Research site

Slovakia Hlavna 38/70, Stare Mesto, 040 01 Kosice, Slovakia

  • 1 trial recruiting
  • Systemic lupus erythematosus · Sjogren's syndrome
  • Adults and children

About Specializations

Zazabie s.r.o. in Kosice, Slovakia specialises in clinical trials of conditions such as Systemic lupus erythematosus, Sjogren's syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology and Autoimmune Diseases

The medical center is at the forefront of research in rheumatology, with a particular focus on autoimmune diseases such as Systemic Lupus Erythematosus (SLE). The center's commitment to understanding and treating these complex conditions is evident through its innovative clinical trials and therapeutic advancements.

  • Systemic Lupus Erythematosus (SLE)
  • Autoimmune Disease Management
  • Innovative Therapeutic Approaches

By conducting cutting-edge research, the center contributes significantly to the development of new treatments that improve patient outcomes and quality of life for those suffering from autoimmune disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hlavna 38/70, Stare Mesto040 01 KosiceSlovakia
Recruiting now
1 trial
Conditions studied
2

More sites in KosiceSlovakia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Sjogren's syndrome

Not yet recruiting

Phase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.